Tumor Models Summit descends on San Francisco for the first time to unite the preclinical and translational oncology community. Pursue the application of more predictable and clinically relevant models for the development of cancer immunotherapies.
Discover the latest preclinical research with exclusive data-driven case studies and lessons learned to maximize the clinical potential of your cancer drug discoveries.
Begin 2017 on the front foot by joining the most trusted conference series dedicated to improving the effectiveness and success of your preclinical oncology research for the development of novel immunotherapies including checkpoint inhibitors and CAR-T therapies.
"Excellent Tumor Models meeting that was very well attended. Great program, speakers and panelists, which made for productive discussions, networking and exchange of ideas." - Genentech